Need ‘whole of govt, society' approach to eliminate TB: PM Modi
Chairing a meeting to review status of National TB Elimination Programme (NTEP), the PM stressed the need to analyse the trends of TB cases in urban or rural areas and based on people's occupations. This, he said, will help identify groups that need early testing and treatment, especially workers in construction, mining, textile mills and similar fields.
The PM also highlighted the importance of cleanliness through Jan Bhagidari (community participation) as a key step in eliminating the disease.
India has set a target for eliminating TB by 2025-end, five years ahead of the global goal. The global End TB Strategy for 2030 says that countries must reduce the number of TB deaths by 90% and new cases by 80% as compared to the levels in 2015.
Towards this goal, the Centre last December launched a 100-day TB Mukt Bharat Abhiyaan in 347 priority districts.
Under this campaign, health workers looked for TB cases among vulnerable individuals such as household contacts of TB patients, under-nourished individuals, those living with HIV, diabetics, smokers and alcoholics, among others. Over 12.9 crore vulnerable individuals were screened and 7.19 lakh new TB cases detected, including 2.85 lakh asymptomatic patients.
The 100-day campaign would further close the gap between the estimated number of TB patients and reported cases. According to the latest available Global TB report, in 2023, of its estimated 28 lakh cases, India reported 25.2 lakh cases.
According to officials in the know of the matter, several technologies and methods tried out during the campaign would be implemented across the country. Training was underway, they said.
One of the key innovations utilised during the campaign — which helped in detecting several of the asymptomatic patients — was the AI driven hand-held X-ray machines. These machines used AI to read the X-rays without a doctor, meaning these tests could be done by minimally trained health workers.
Another key method was Jan Bhagidari — the participation of parliamentarians, Assembly members, local government representatives, officials and members of the public.
During the meeting, Modi was informed that over 1 lakh new Nikshay Mitras — who provide nutritional support to TB patients during treatment — had augmented the campaign, along with `1,000 support from government.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 hours ago
- Time of India
Qure.ai equipped to resist the Grim Reaper? : Qure.ai takes on the Diagnostic gaps with its Deep Learning Model.
How does qXR work? Live Events How does qER work? The qXR was launched in 2017, having been trained on millions of scans and subsequently earning a CE certification (a regulatory approval mark that shows a product meets European Union health and safety standards), WHO endorsement for TB triage, and FDA clearance, breaking ground for AI tools validated by real-world medical as mentioned prior, is an AI-powered chest X-ray interpretation tool curated by It inculcates deep learning to analyze chest radiographs and detect abnormalities such as tuberculosis, pneumonia (not excluding COVID-19), lung nodules, fibrosis, and functions by processing the image first, wherein the model analyzes the X-ray, cleans it, and then standardizes it. It then adjusts the brightness and contrast so that images from different machines are easily comparable. The model then resizes the images and crops them so they focus on the chest region. The AI model also removes artifacts such as text labels, ECG leads, or any noise that may interfere with also uses convolutional neural networks (CNN), a type of deep learning model that is able to automatically identify patterns in the chest X-ray that are linked to the diseases. This process is referred to as 'feature extraction.' CNN learns features such as opacities (the cloudy areas in the lungs), cavities (hollow areas commonly found in TB patients), consolidation (fluid-filled lung sections), and pleural effusion (fluid around the lungs).Upon having these features extracted, the deep learning model interprets if the image shows any sign of a disease. It runs the image through pre-trained classification models to garner a numerically derived result, for example, '92% chance of tuberculosis.'The platform, to make the results easily explainable, overlays a heatmap on the X-ray to show which areas are the most likely to be severely affected and which are not. The heatmap tool used for this purpose is called a 'saliency map.' This visual tool highlights regions that the AI focused on, garnering results that claim 'AI saw pneumonia in this area,' proceeding to paint that area in last step involved in this procedure is having to generate a report. The AI model is enabled to automatically generate a report in the appropriate 2018, Qure fulfilled its ambition to extend into CT-based diagnostics, subsequently introducing qER for urgent cases that involve hemorrhages, strokes, and fractures, scanning and triaging results in under ten seconds, proving itself to be an essential tool when entering the time-critical window for stroke intervention. As COVID-19 struck the world silent, Qure's qXR was used for early detection of pneumonia and viral lung patterns, helping fill the accessibility-related gaps in RT-PCR testing, particularly in resource-limited procedure begins with image acquisition and processing, where a non-contrast head CT scan is captured and the images are standardized using preprocessing, much like how qXR does chest X-rays, which are 2D, CT scans are 3D data volumes wherein multiple image slices are placed atop one another. Therefore, in contrast to qXR, qER uses 3D CNN to process the scan in full. The model then identifies patterns across the multiple layers, aiming to spot signs of bleeding within the brain tissue (intraparenchymal hemorrhage), bleeding between the brain layers (subdural/epidural hematoma), and bleeding in the brain's surface vessels (subarachnoid hemorrhage and cranial fractures).Further, there exists the process of abnormality detection, where each abnormality is scored based on probability, localization (highlighting the exact region in the brain), and urgency (how quickly a radiologist or ER team should be intervening). The abnormal areas, upon being identified, are then highlighted using the previously mentioned saliency maps, giving radiologists visual cues about what the AI saw and qER detects the critical issues and instantly alerts the radiologist or the ER team for momentary its product suite proving clinical value in both routine screenings and emergency care, 's technological strides soon began translating into significant investor interest and global company's financial backing has fueled its expansion and also global outreach. In September 2024, closed a $65 million Series D round to deepen its presence in the United States and advance AI foundation models and acquisitions. As of November 2024, it had raised $125 million, with the company now worth around $264 million in the market, backed by major investors. The company portrays strong growth wherein its revenues are skyrocketing at 60–70% annually, and now serves approximately 15 million patients each year, with around 25% of its revenue coming from the US climbed up the pedestal in the industries and geographies. Today, its solutions are deployed at over 3,100 sites in more than 90 countries, including NHS hospitals in the UK, major centers in the US, mobile X-ray vans in the Philippines, and even equine ambulances in Lesotho, supporting around 25 million people worldwide. Investors believe this global footprint highlights the company's relevance across markets. 'Qure is making quality healthcare accessible in the US and Europe as well as globally in Asia, Africa, and Latin America," added Dev Khare, Partner, startup has also made clinical partnerships with industry giants and public health services, embedding tools into public health programs, screening drives, and pharmaceutical ahead, is working toward profitability in the next financial year, with plans for an IPO within two years, throwing light onto its ambition to bring AI into mainstream healthcare diagnostics. As global healthcare costs rise, diagnostic backlogs grow, and workforce limitations persist, product line featuring qXR, qER, stroke triage tools, and patient management apps is becoming a pivotal offering in modern shift is especially relevant amid widening diagnostic gaps and rising demand for radiology services across both developed and underdeveloped regions. 'AI helps to overcome healthcare bottlenecks, from imaging reporting backlogs to workforce shortages, not only in Western societies like the US and Europe but also in developing nations,' said Prashant Warier, co-founder and CEO of conclude, stands not just as a startup but as a healthcare infrastructure builder: democratizing radiological expertise, enabling early diagnosis of life-threatening diseases, and empowering clinicians worldwide. Its trajectory from AI-powered X-ray and CT tools to near-term IPO ambitions marks it as one of India's most significant contributions to global healthcare innovation.
Indian Express
18 hours ago
- Indian Express
‘Target is to stop spread': Screening camps at Delhi's urban slums strengthen fight against TB
Sheela Devi (48), a resident of Indira Kalyan Vihar, a jhuggi jhopri cluster in Southeast Delhi's Okhla Industrial Area Phase-1, stepped out to buy vegetables when Subhash, the village head or pradhan as they call him, asked her to visit the TB screening camp operating from his office. The screening was long overdue, she thought to herself. She has been suffering from fever for the last few months and coughs excessively. 'There is a persistent cough and fever which doesn't fade away,' she added. Her X-ray showed abnormalities and cavities in her lungs. 'Now, we will send her to the Nehru Nagar centre where her sputum samples will be collected for further evaluation,' explained District TB officer Dr Umesh Kumar. The village head has lent his office space for a screening camp under the Delhi government's TB programme for free for a month. A team of doctors, under the National TB Elimination Programme (NTEP), are screening patients with the help of a handheld X-Ray machine and AI software, which identifies abnormalities in the lungs and is said to have minimal radiation exposure. According to the 2019-2021 National TB Prevalence Survey, Delhi was identified as having the highest TB prevalence in India, with 747 cases per lakh population. Under the NTEP, Delhi has been conducting screening drives in urban slums and has started the first phase of the programme targeting six high-burden areas — Nehru Nagar, Narela, Karawal Nagar, Moti Nagar, Babu Jagjivan Ram Memorial Hospital's chest clinic and Shastri Nagar. In Nehru Nagar, five areas have been targeted — Indira Kalyan Vihar, Jaitpur, Pul Prahladpur, Nizamuddin and Batla House. To drive engagement, doctors and volunteers also conduct door-to-door drives, and announcements are made on loudspeakers as well. Five X-ray machines have been set up in each camp in the slums of South Delhi. 'The programme has been functioning since last December, and we started again in June this year. Our target is to stop the spread of TB, and we need to do catchment at the mass level. Except pregnant women and children below 15 years, everyone else is being screened,' Dr Umesh explained. Since June, more than 10,000 people have been screened, and around 40 people have been identified as TB affected at such camps across the city, said sources. Along with the mass-level screening, these camps provide prevention therapy to people who are at high risk — they collect the medicines from the nearby DOT centre, a healthcare facility focused on tuberculosis. 'Before prescribing medicines under TB prevention therapy, we confirm about latent TB infection by the Cy-Tb test, a modern skin test for detecting Mycobacterium tuberculosis infection, a bacterium that causes tuberculosis. If it is positive in TB contact persons, we give them the preventive therapy,' underlined Dr Umesh Kumar. For this, the doctors deployed are particularly targeting the high-risk group, which includes patients with diabetes, those with alcohol or cigarette addiction, those who are not gaining weight and those who are living in families where someone had TB in the last five years. The camp at Indira Kalyan Vihar Jhuggi has been conducting 150-200 X-rays daily at the centre. Even as 5-10% of X-rays highlight abnormalities on average every day, not all of these patients test positive for TB. 'The X-rays highlight if there is fluid in the lungs, signs of pneumonia, old or new pneumonia and cavities in the lungs. If these abnormalities are found, we send the patient for further tests,' said Dr Umesh. With the X-ray machines, screening takes just 5-10 minutes, and the visitors can get details added to the system, which is convenient for many. One doctor, one technician and one patient mobiliser and a volunteer for registration of people have been deployed at each camp. Meanwhile, more women than men are visiting the camp at Indira Kalyan Vihar, according to the team. 'This may be because most of the women are at home, and the men of the house go to work. Which is why we are taking this till 4 pm to target the men as well,' said Himansh Parewa, junior field officer who has been mobilising people from the jhuggi cluster. 'We mobilise the community with the help of ANM and ASHA workers and TB health workers from the Dot centres,' he added. However, this does not mean more women are testing positive. 'Diabetics, malnourished smokers, those with a family history of TB have the highest prevalence, along with those who are living in poorly ventilated areas, which makes slum areas more at risk,' explained Dr Umesh. A majority of men in the area, according to Himansh, are factory workers who have to leave for work early morning, due to which it remains a challenge to screen them.
Mint
a day ago
- Mint
Centre to deregulate household antiseptic sales
New Delhi: The health ministry is set to deregulate the sale of common household liquid antiseptics, with a new policy in the works for easing wholesale licensing requirements for these products. Currently, only retail sales of household antiseptics bought from licensed wholesalers are exempt from licensing, two officials and documents reviewed by the Mint said. Household liquid antiseptics are those used for cleaning wounds or sanitizing surfaces at home such as Dettol and Savlon. Also read | India restricts sale of TB drugs to government channels to curb resistance This proposed change, supported by the Drugs Consultative Committee (DCC), aims to make hygiene products both more affordable and easier for consumers to access. It will also benefit companies that produce and sell liquid antiseptics, which are frequently used in homes for first aid on living tissues and have historically faced stricter regulations. The move comes in the backdrop of the Centre's plan to allow non-prescription drugs sales at neighbourhood stores. Matter discussed A discussion on this matter took place at the 66th meeting of the Drugs Consultative Committee (DCC) held last month chaired by the Drugs Controller General of India (DCGI). Currently, there's a difference in how antiseptics and disinfectants are treated. While disinfectants, typically used for general cleaning purposes, are usually exempt from requiring special sales licenses, antiseptics, which are specifically designed for application to living tissues, have always been more regulated. Also read | Centre asks states to tackle over-the-counter sale of prescription drugs 'This issue is in consideration from 2022 to make household liquid antiseptics easier to buy. They were allowed to be sold without a special retail license, as long as they were purchased from a licensed wholesaler or manufacturer. Now, the industry is pushing even further, asking to remove the need for a wholesale license altogether for these products," said the official familiar with the matter. A meeting was also held in May 2025 with the pharmaceutical companies and associations to take this matter forward. Clearer approach The official said that the government has suggested a clearer approach, i.e. divide antiseptics into two main groups. One group would be "household/daily use" antiseptics, and the other would be "hospital grade" antiseptics. 'The idea is that the stronger, hospital-grade versions would still only be sold in licensed medical stores. But, everyday household antiseptics could be sold in regular shops, much like other common household items," the official added, adding that the matter will be taken up by the Drugs Technical Advisory Board (DTAB), a key advisory body. 'A draft rule was even prepared to change the existing regulations. However, the ministry recommended getting more input from various interested parties and discussing it further," a second official aware of the matter said. Also read | Govt doctors told to give suggestions on over-the-counter drugs in 3 months 'The DTAB will now consider all these points and make its recommendations on the matter. If approved, this could mean that picking up a bottle of household antiseptic might become as straightforward as buying other daily necessities from your local store," the official added. Krishna Khatwani, Head of Sales (India), Godrej Consumer Products Ltd said that dedicated antiseptic brands may benefit from increased distribution following deregulation. Queries sent to the health ministry spokesperson, DCGI, and antiseptic makers ITC, Reckitt, Apollo Pharmacy and HUL remained unanswered.
